Barber Daniel
Insider CIK 1742266 · AQST SVP-Chief Strategy/Dev Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | S Sale | 2026-10-15 | 2026-10-16 | 25,000 | $4.22 | $105.6K | 627,317 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-09-15 | 2026-09-16 | 25,000 | $4.82 | $120.5K | 652,317 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-09-15 | 2026-09-16 | 25,000 | $4.82 | $120.5K | 652,317 | SEC↗ |
| AQST Aquestive Therapeutics, In | X Exercise deriv | 2026-09-08 | 2026-09-09 | 91,743 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | X Exercise | 2026-09-08 | 2026-09-09 | 91,743 | $0.96 | $88.1K | 677,317 | SEC↗ |
| AQST Aquestive Therapeutics, In | X Exercise deriv | 2026-09-08 | 2026-09-09 | 91,743 | — | $0 | 0 | SEC↗ |
| AQST Aquestive Therapeutics, In | X Exercise | 2026-09-08 | 2026-09-09 | 91,743 | $0.96 | $88.1K | 677,317 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-08-17 | 2026-08-18 | 25,000 | $4.29 | $107.3K | 585,574 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-08-17 | 2026-08-18 | 25,000 | $4.29 | $107.2K | 585,574 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-07-16 | 2026-07-17 | 20,369 | $4.00 | $81.5K | 610,574 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-07-15 | 2026-07-17 | 4,631 | $4.03 | $18.7K | 630,943 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-06-15 | 2026-06-16 | 25,000 | $4.16 | $104.0K | 635,574 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-05-15 | 2026-05-18 | 8,257 | $4.29 | $35.4K | 660,574 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2026-05-05 | 2026-05-07 | 335,922 | $4.18 | $1.40M | 668,831 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-03-10 | 2026-03-11 | 180,677 | $4.17 | $753.4K | 1,004,753 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2026-03-09 | 2026-03-11 | 523,000 | $4.29 | $2.24M | 523,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2026-03-09 | 2026-03-11 | 262,000 | — | $0 | 1,185,430 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2025-09-26 | 2025-09-29 | 91,343 | $6.03 | $550.8K | 923,430 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2025-09-19 | 2025-09-22 | 400 | $6.00 | $2.4K | 1,014,773 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-09 | 2025-03-11 | 53,998 | $2.65 | $143.1K | 1,015,173 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2026-04-13 | 293,100 | — | $0 | 293,100 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2025-03-11 | 408,000 | — | $0 | 408,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2025-03-07 | 2025-03-11 | 272,000 | — | $0 | 1,098,478 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-07 | 2025-03-11 | 29,307 | $2.65 | $77.7K | 1,069,171 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-10-02 | 56,824 | $4.88 | $277.3K | 826,478 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-03-12 | 37,938 | $4.88 | $185.1K | 845,364 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-03-07 | 2024-03-11 | 363,900 | — | $0 | 363,900 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-03-07 | 2024-03-11 | 242,600 | — | $0 | 883,302 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-08-09 | 2023-08-09 | 223,500 | — | $0 | 223,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-05-05 | 2023-05-05 | 223,500 | — | $0 | 223,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-03-09 | 2023-03-09 | 447,000 | — | $0 | 640,702 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-08-05 | 2022-08-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy deriv | 2022-06-08 | 2022-06-10 | 91,743 | $0.13 | $11.9K | 91,743 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2022-06-08 | 2022-06-10 | 91,743 | $0.96 | $88.1K | 193,702 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-03-10 | 2022-03-14 | 225,000 | — | $0 | 225,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-03-11 | 2021-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 110,000 | — | $0 | 110,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-27 | 2019-08-27 | 2,000 | $3.99 | $8.0K | 101,959 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-05-09 | 2019-05-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-02-28 | 2019-03-04 | 70,000 | — | $0 | 70,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-12-10 | 2018-12-10 | 1,000 | $8.00 | $8.0K | 99,959 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-07-24 | 2018-07-26 | 96,507 | — | $0 | 96,507 | SEC↗ |